Mauclère-Denost, Sophie <br/><br/>
High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up.  [electronic resource] 

 -  European journal of endocrinology  Feb 2012 
 - 261-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1479-683X 
<br/><br/><label>Standard No.: </label>10.1530/EJE-11-0557  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Neoplasms--blood<br/>Adrenocortical Carcinoma--blood<br/>Adult<br/>Aged<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Blood Chemical Analysis<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Mitotane--administration & dosage<br/>Osmolar Concentration<br/>Time Factors